Skip to content

Value Assessment and Health Outcomes Research Scientific Advisory Committee

Value Assessment and Health Outcomes Research

Eberechukwu Onukwugha, MS, PhD (Chair)

Executive Director, Pharmaceutical Research Computing
Associate Professor, Dept. of Pharmaceutical Health Services Research

University of Maryland School of Pharmacy
Junling Wang, PhD (Co-Chair)

Professor & Vice Chair for Research
Dept. of Clinical Pharmacy & Translational Science
College of Pharmacy

University of Tennessee
Aasthaa Bansal, PhD

Associate Professor, Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute

University of Washington
Benjamin Craig, PhD

Associate Professor of Economics

University of South Florida
Elizabeth Franklin, PhD, MSW

Head, US Public Affairs and Patient Advocacy, Oncology

Jan Hansen, PhD

Vice President, Evidence for Access Unit
US Medical Affairs

Marianne Laouri, PhD

Executive Director, Value Demonstration Team

Boehringer Ingelheim Pharmaceuticals, Inc.
Pei-Jung “Paige” Lin, PhD

Associate Professor of Medicine
Center for the Evaluation of Value & Risk in Health, Institute for Clinical Research & Health Policy Studies

Tufts Medical Center
R. Brett McQueen, PhD

Associate Professor
Skaggs School of Pharmacy

University of Colorado
Philip Naughten, PharmD

Vice President, HEOR

Christian Nguyen, PharmD, MBA, MS

Vice President, Global Patient Outcomes and Real World Evidence

Eli Lilly and Company
Megan O’Brien, PhD

Associate Vice President, CORE

Shelby D. Reed, PhD, RPh

Professor, Depts. of Medicine and Population Health Sciences
Director, Preference Evaluation Research
Group, Center for Informing Health Decisions
Duke Clinical Research Institute

Duke University
Sarah E. Tom, PhD, MPH

Assistant Professor of Epidemiology

Columbia University
Tatia Woodward

Vice President
Value and Evidence Strategy Lead

Gergana Zlateva, PhD

Vice President, Patient & Health Impact, Oncology